ELVN R&D Expenses
Enliven Therapeutics Inc · R&D Expenses
ELVN R&D Expenses
Latest reported$29.00Mperiod ending
ELVN Quarterly R&D Expenses ($3.56M → $29.00M)
Quarterly R&D Expenses
High-resolution chart · PNG
ELVN r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 28,996,000 | |
| 20,687,000 | |
| 21,245,000 | |
| 18,225,000 | |
| 21,491,000 | |
| 24,895,000 | |
| 20,724,000 | |
| 21,258,000 | |
| 18,826,000 | |
| 19,970,000 | |
| 17,905,000 | |
| 19,606,000 | |
| 15,183,000 | |
| 11,880,000 | |
| 8,197,000 | |
| 7,829,000 | |
| 7,937,000 | |
| 7,059,000 | |
| 6,864,000 | |
| 10,397,000 | |
| 10,074,000 | |
| 7,115,000 | |
| 8,959,000 | |
| 9,533,000 | |
| 7,869,000 | |
| 5,793,000 | |
| 5,942,000 | |
| 5,141,000 | |
| 4,366,000 | |
| 3,560,000 |